Armistice Capital, Llc Insider Trades

Insider Trading History

Track insider trading activity for Armistice Capital, Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $9.96M 731,458 shares
Last Trade
Jun 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$96.7M 937,404 shares
$103.20
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $22.7M 1,668,862 shares
Last Trade
Jun 26, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$330M 2,746,138 shares
$120.00
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $60.1M 4,415,000 shares
Last Trade
Feb 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$374M 450,000 shares
$830.40
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $54M 3,965,000 shares
Last Trade
Feb 03, 2023 Purchase (Small Acquisition)A small acquisition that may be exempt from certain SEC reporting thresholds.
$312k 334 shares
$933.60
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $637M 46,840,000 shares
Last Trade
Feb 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90.4M 40,000 shares
$2,260.80
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $637M 46,800,000 shares
Last Trade
Feb 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$239M 100,000 shares
$2,394.43
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $636M 46,700,000 shares
Last Trade
Feb 22, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$191M 83,000 shares
$2,303.71
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $634M 46,617,000 shares
Last Trade
Feb 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131M 55,000 shares
$2,377.73
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $634M 46,562,000 shares
Last Trade
Feb 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$357M 150,000 shares
$2,376.86
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $632M 46,412,000 shares
Last Trade
Jan 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.1M 12,000 shares
$2,595.74
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $630M 46,306,300 shares
Last Trade
Jan 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$536M 206,300 shares
$2,595.74
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $632M 46,400,000 shares
Last Trade
Jan 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$243M 93,700 shares
$2,595.74
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $627M 46,100,000 shares
Last Trade
Jan 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$245M 85,000 shares
$2,879.42
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $626M 46,015,000 shares
Last Trade
Jan 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$864M 312,700 shares
$2,761.63
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $622M 45,702,300 shares
Last Trade
Jan 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$170M 57,300 shares
$2,966.40
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $621M 45,645,000 shares
Last Trade
Jan 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44M 16,003 shares
$2,752.13
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $621M 45,628,997 shares
Last Trade
Jan 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.38B 491,097 shares
$2,809.44
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $614M 45,137,900 shares
Last Trade
Jan 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$413M 137,900 shares
$2,995.20
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $612M 45,000,000 shares
Last Trade
Sep 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$39.9B 5,454,545 shares
$7,315.20
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
10% owner
Holding Value $538M 39,545,455 shares
Last Trade
Sep 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1B 150,000 shares
$6,681.60
$13.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up